Ibrutinib

• Synonyms:

  1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one; (R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one; CRA 032765; Ibrutinib; Imbruvica; JNJ 02; PCI 32765; PCI 32765-00

• Hazard Statement:

  Harmful if swallowed

• Purity:

  >95% (HPLC)

• Smiles:

  Nc1ncnc2c1c(nn2[C@@H]3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4

• Molecular Formula:

  C25 H24 N6 O2

• Molecular Weight:

  440.5

• InChI:

  InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1

• Additionnal Information:

  IUPAC name: 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  +4°C

• CAS Number:

  936563-96-1